RJT
BIIB icon

Raymond James Trust’s Biogen BIIB Stock Holding History

Raymond James Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$580K Buy
2,993
+80
+3% +$16.7K 0.01% 714
2024
Q2 		$675K Sell
2,913
-55
-2% -$12K 0.02% 599
2024
Q1 		$640K Buy
2,968
+349
+13% +$81.7K 0.02% 611
2023
Q4 		$678K Sell
2,619
-83
-3% -$20.4K 0.02% 568
2023
Q3 		$694K Buy
2,702
+47
+2% +$12.6K 0.02% 519
2023
Q2 		$757K Buy
2,655
+37
+1% +$11K 0.02% 498
2023
Q1 		$728K Sell
2,618
-133
-5% -$36.8K 0.02% 494
2022
Q4 		$762K Sell
2,751
-108
-4% -$30.5K 0.03% 465
2022
Q3 		$764K Sell
2,859
-92
-3% -$19.5K 0.03% 440
2022
Q2 		$602K Sell
2,951
-343
-10% -$70.1K 0.02% 529
2022
Q1 		$693K Buy
3,294
+464
+16% +$101K 0.02% 521
2021
Q4 		$679K Sell
2,830
-261
-8% -$67.1K 0.02% 541
2021
Q3 		$875K Buy
3,091
+291
+10% +$95.4K 0.03% 438
2021
Q2 		$970K Sell
2,800
-6
-0.2% -$1.82K 0.03% 412
2021
Q1 		$785K Sell
2,806
-254
-8% -$68.5K 0.03% 431
2020
Q4 		$749K Sell
3,060
-53
-2% -$13.7K 0.03% 412
2020
Q3 		$883K Sell
3,113
-279
-8% -$77.8K 0.04% 350
2020
Q2 		$907K Sell
3,392
-740
-18% -$222K 0.04% 325
2020
Q1 		$1.31M Sell
4,132
-1,077
-21% -$327K 0.08% 224
2019
Q4 		$1.55M Sell
5,209
-821
-14% -$228K 0.07% 229
2019
Q3 		$1.4M Buy
6,030
+505
+9% +$118K 0.07% 244
2019
Q2 		$1.29M Sell
5,525
-138
-2% -$31.9K 0.07% 242
2019
Q1 		$1.34M Sell
5,663
-731
-11% -$230K 0.08% 228
2018
Q4 		$1.92M Sell
6,394
-295
-4% -$94.1K 0.12% 173
2018
Q3 		$2.36M Buy
6,689
+712
+12% +$245K 0.13% 163
2018
Q2 		$1.74M Buy
5,977
+565
+10% +$159K 0.11% 198
2018
Q1 		$1.48M Buy
5,412
+193
+4% +$59.9K 0.1% 204
2017
Q4 		$1.66M Buy
5,219
+560
+12% +$180K 0.11% 185
2017
Q3 		$1.46M Sell
4,659
-54
-1% -$16K 0.1% 196
2017
Q2 		$1.28M Sell
4,713
-183
-4% -$48.4K 0.1% 202
2017
Q1 		$1.34M Buy
4,896
+424
+9% +$120K 0.1% 204
2016
Q4 		$1.27M Buy
4,472
+822
+23% +$244K 0.1% 202
2016
Q3 		$1.14M Buy
3,650
+372
+11% +$110K 0.1% 198
2016
Q2 		$793K Sell
3,278
-299
-8% -$78.8K 0.07% 249
2016
Q1 		$932K Sell
3,577
-838
-19% -$221K 0.09% 224
2015
Q4 		$1.35M Buy
4,415
+1,347
+44% +$387K 0.12% 168
2015
Q3 		$895K Sell
3,068
-176
-5% -$58.1K 0.1% 194
2015
Q2 		$1.31M Sell
3,244
-300
-8% -$120K 0.14% 154
2015
Q1 		$1.5M Sell
3,544
-291
-8% -$115K 0.16% 141
2014
Q4 		$1.3M Sell
3,835
-119
-3% -$38.5K 0.14% 158
2014
Q3 		$1.31M Buy
3,954
+709
+22% +$234K 0.15% 144
2014
Q2 		$1.02M Buy
3,245
+104
+3% +$31.3K 0.12% 184
2014
Q1 		$961K Sell
3,141
-1
-0% -$317 0.12% 183
2013
Q4 		$878K Buy
3,142
+456
+17% +$118K 0.12% 182
2013
Q3 		$647K Buy
2,686
+207
+8% +$46.3K 0.1% 207
2013
Q2 		$534K Buy
+2,479
New +$530K 0.09% 221

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Raymond James Trust's BIIB Position: Q3 2024 in Review

Raymond James Trust increased its Biogen (BIIB) stake by 2.7% in Q3 2024, buying an estimated $16.7K and bringing the position to 2,993 shares worth $580K. The position accounts for 0.01% of the portfolio, ranked #714.

Raymond James Trust first reported a position in BIIB in Q2 2013 and has held it in 46 quarters since. The position peaked at $2.36M in Q3 2018. 916 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Raymond James Trust held 2,993 shares of Biogen worth $580K as of Q3 2024.
  • Raymond James Trust bought 80 Biogen shares in Q3 2024, an estimated $16.7K.
  • Biogen made up 0.01% of Raymond James Trust's portfolio in Q3 2024, its #714 holding.
  • Raymond James Trust first reported a position in Biogen in Q2 2013 and has held it in 46 quarters since.
  • Raymond James Trust's Biogen position peaked at $2.36M in Q3 2018.
  • 916 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.